Products

API’sCategorySpecificationsRegulatory Status
 AtenololAnti-HypertensiveIP/BP/EP/USPCEP, EU GMP
 Amlodipine BesylateAnti-HypertensiveIP/BP/EP/USPDMF Available
 Metoprolol SuccinateAnti-HypertensiveIP/BP/EP/USPDMF Available
 Metoprolol TartrateAnti-HypertensiveIP/BP/EP/USPDMF Available
 RoxithromycinMacrolidesIP/BP/EPCEP, KFDA
 AzithromycinMacrolidesIP/BP/EP/USPCEP
 Clarithromycin Granules 27.5%MacrolidesIn-HouseDMF Available
 Clarithromycin Granules 33%MacrolidesIn-House 
 Clarithromycin Granules 43%MacrolidesIn-HouseDMF Available
 PregabalinNeuromodulatorIP/EP/In-HouseEU DMF available
and CEP applied
 Ceftriaxone SodiumSterile CephalosporinsIP/BP/EP/USPDMF Available
 Cefotaxime SodiumSterile CephalosporinsIP/BP/EP/USPDMF Available
 Cefepime (with L-Arginine) for
Injection
Sterile CephalosporinsIP/USP 
 Meropenem (with Sodium
Carbonate) for Injection
CarbapenemsIP/USPDMF Available
 DoripenemCarbapenemsIn-HouseDMF Available
 BiapenemCarbapenemsIn-HouseDMF Available
 TebipenemCarbapenemsIn-House 
 LymecyclineAnti-Acne,
Anti-Infective
EPDMF Available
 NitroxolineUrologicalIn-HouseDMF Available

Products under development

API’sCategoryR&D Sample availabilityR&D Tech packSpecifications
TicagrelorAnti-ThromboticAvailableApr.2020IP/ In-House
ApixabanAnti-ThromboticAvailableAvailableIn-House
RivaroxabanAnti-ThromboticAvailableAvailableIn-House
CanagliflozinAnti-DiabeticAvailableSep. 2020In-House
DapagliflozinAnti-DiabeticAvailableApr.2020In-House
EmpagliflozinAnti-DiabeticAvailableJun.2020In-House
Imipenem (Non-Sterile)CarbapenemsAvailableJun.2020USP
ErtapenemCarbapenemsJun.2020Apr.2020In-House
FaropenemCarbapenemsAvailableOct. 2019In-House
Ceftaroline FosamilSterile CephalosporinsApr.2020Aug.2020In-House